Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

6885.TW

STRONG SELLREMOVE

BRIM Biotechnology, Inc. · Healthcare · Taiwan · $91M · Avg Vol: $431K/d

9
StockRank
Q
36
V
28
M
21
P/E (TTM)
—
ROE
-24.9%
D/E
0.0x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
AI CONVICTION THESIS

A pre-revenue Taiwanese biotech company with high development risks and no structural moat, failing our quality compounder criteria.

COMPANY DESCRIPTION

BRIM Biotechnology, Inc. develops novel translational therapeutics, focusing on regenerative peptides for ophthalmology and oncology. The company utilizes its proprietary PDSP technology platform to accelerate early-stage drug development and secure global licensing deals. It is a virtual-model biopharmaceutical company specializing in efficient translational medicine and peptide therapeutics.

FINANCIAL SUMMARY (USD)

Year20212022202320242025CAGR
Revenue—16,6202,84410,5220.2M118.5%
EPS-0.05-0.12-0.22-0.09——
Shares—96.4M115.8M131.6M133.2M+38.1%
Debt—0.2M0.1M0.2M0.5M35.3%
Equity—28.9M54.9M65.0M52.3M21.9%
Op CF—-5.4M-18.9M-8.8M-10.4M—
Inv CF—0.7M-23.7M-21.0M20.5M—
Fin CF—18.6M46.1M15.8M-0.8M—
Loading...
PRICE (1Y)-3.0%
0.650.700.750.790.84May 12Jun 2Jun 23
SMA 50SMA 200
Close
$0.67
RSI (14)
33.3
52W High
$1.30
From 52W High
0.5%

SCORE BREAKDOWN

Quality
36
ROIC
-25.6%25.3
ROE
-24.9%28.0
GP/Assets
0.1%10.5
Op. Margin
-2956.8%4.4
FCF/Assets
-47.7%5.0
Piotroski
430.3
Int. Cover
-50.0x6.0
D/E Ratio
0.01x90.1
Current Ratio
27.33x97.4
Value
28
P/E (TTM)
—N/A
EV/EBITDA
-4.9x25.0
P/FCF
—N/A
P/B
1.9x61.5
P/S
372.5x4.3
Div Yield
—N/A
Momentum
21
52W High %
52%29.7
RS 6M
-92%10.8
SMA 50/200
0.83x18.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$91M
P/E (Forward)
—
Gross Margin
11.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 6885.TW are excluded.

TickerCompanyMkt CapStockRankSignal
6885.TWBRIM Biotechnology, Inc.(you)$91M9STRONG SELL
6657.TWEnergenesis Biomedical CO.,LTD.$101M8STRONG SELL
6461.TWOIntech Biopharm Corporation$84M6STRONG SELL
6733.TWOBioGend Therapeutics Co., Ltd.$102M12STRONG SELL
4178.TWStemCyte International, Ltd.$117M12STRONG SELL
4168.TWOGlycoNex Incorporation$91M17STRONG SELL
MENSJyong Biotech Ltd.$121M4STRONG SELL
6838.TWFormosa Pharmaceuticals, Inc.$116M15STRONG SELL
4174.TWOOBI Pharma, Inc.$116M1STRONG SELL
6492.TWOSenhwa Biosciences, Inc.$121M17STRONG SELL

Peer medians: ROE 3.6% · P/E 16.2x · Gross margin 42.1%

BRIM Biotechnology, Inc. (6885.TW) — Stock Score Summary

BRIM Biotechnology, Inc. (6885.TW) has a MoatMap StockRank of 9/100 based on Quality (36/100), Value (28/100), and Momentum (21/100) factor scores. The current signal is STRONG SELL. A pre-revenue Taiwanese biotech company with high development risks and no structural moat, failing our quality compounder criteria.

BRIM Biotechnology, Inc. develops novel translational therapeutics, focusing on regenerative peptides for ophthalmology and oncology. The company utilizes its proprietary PDSP technology platform to accelerate early-stage drug development and secure global licensing deals. It is a virtual-model biopharmaceutical company specializing in efficient translational medicine and peptide therapeutics.

Key Financial Metrics

Price$0.67
Market Cap$91M
Price/Book1.89
Return on Equity-24.9%
Return on Invested Capital-25.6%
Debt/Equity0.79
Gross Margin11.2%
Operating Margin-2956.8%
Revenue Growth2723.0%
Free Cash Flow$-874K

BRIM Biotechnology, Inc. operates in the Biotechnology industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is BRIM Biotechnology, Inc.’s (6885.TW) StockRank?
MoatMap’s StockRank for BRIM Biotechnology, Inc. (6885.TW) is 9/100, with a Strong Sell signal. It is a composite of Quality (36), Value (28), and Momentum (21) factor ranks across MoatMap’s 20,000+ stock universe.
Does BRIM Biotechnology, Inc. have an economic moat?
BRIM Biotechnology, Inc. (6885.TW) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is BRIM Biotechnology, Inc. a buy, hold, or sell?
MoatMap’s current signal for BRIM Biotechnology, Inc. (6885.TW) is Strong Sell, based on a StockRank of 9/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is BRIM Biotechnology, Inc. in?
BRIM Biotechnology, Inc. (6885.TW) operates in the Healthcare sector, specifically the Biotechnology industry (Taiwan).
Browse all ranked stocks6885.TW deep dive reportAI ChampionsHow we score stocksSense-check another stock